Modulators of neuronal regeneration

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100

Reexamination Certificate

active

07943329

ABSTRACT:
The present invention provides methods and compositions related to CNS function and diseases.

REFERENCES:
patent: 2003/0049254 (2003-03-01), Kaufman et al.
patent: 2003/0113326 (2003-06-01), He et al.
patent: 2003/0170690 (2003-09-01), Shatz
patent: 2005/0048520 (2005-03-01), Strittmatter
patent: WO 03/51834 (2003-06-01), None
Atwal JK et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science, Nov. 2008; 322:967-970.
Filbin MT. PirB, a second receptor for the myelin inhibitors of axonal regeneration Nogo66, MAG, and OMgp: Implications for regeneration in vivo. Neuron, Dec. 2008; 60:740-742.
Giger RJ et al. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Restor Neurol Neurosci. 2008; 26(2-3):97-115.
Thams S et al. Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction. J Neurosci. Oct. 2009; 29(43):13503-13515.
Pushparaj PN and Melendez AJ. Short interfering RNA (siRNA) as a novel therapeutic. Clin Exp Pharmacol Physiol. 2006; 33:504-510.
Shiroishi, et al., “Human inhibitory receptors lg-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class 1 binding and bind preferentially to HLA-G”, PNAS vol. 100, No. 15, pp. 8856-8861, (2003).
Borges, et al., “A family of human lymphoid and myeloid lg-like receptors, some of which bind to MHC class 1 molecules”, The Journal of Immunology, 159: 5192-5196, (1997).
Boulanger, et al., “Immune signaling in neural development, synaptic plasticity and disease”, Nature Reviews, vol. 5, pp. 521-531, (2004).
Chen, et al., “Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1”, Nature, vol. 403, pp. 434-439, (2000).
Colonna, et al., “A common inhibitory receptor for major histocompatibility complex class 1 molecules on human lymphoid and myelomonocytic cells”, J. Exp. Med., vol. 186, No. 11, pp. 1809-1818, (1997).
Fournier, et al., “Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration”, Nature, vol. 409, pp. 341-346, (2001).
GrandPre, et al., “Identification of the Nogo inhibitor of axon regeneration as a reticulon protein”, Nature, vol. 403, pp. 439-444, (2000).
GrandPre, et al., “Nogo-66 receptor antagonist peptide promotes axonal regeneration”, Nature, vol. 417, pp. 547-551, (2002).
Hayami, et al., “Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors”, The Journal of biological chemistry, vol. 272, No. 11, pp. 7320-7327, (1996).
Kim, et al., “Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury”, Neuron, vol. 44, pp. 439-451, (2004).
Kottis, et al., “Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth”, Journal of Neurochemistry, 82: 1566-1569, (2002).
Kubagawa, et al., “A novel pair of immunglobulin-like receptors expressed by B cells and myeloid cells”, PNAS, vol. 94, pp. 5261-5266, (1997).
Li, et al., “Delayed systemic nogo-66 receptor antagonist promotes recovery from spinal cord injury”, The Journal of Neuroscience, 23(10): 4219-4227, (2003).
Liang, et al., “HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor”, Eur. J. Immunol., 32: 2418-2426, (2002).
McKerracher, et al., “Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth”, Neuron, vol. 13, pp. 805-811, (1994).
Nakamura, et al., “Exacerbated graft-versus-host disease in Pirb-1-mice”, Nature Immunology, vol. 5, No. 6, pp. 623-629, (2004).
Prinijha, et al., “Inhibitor of neurite outgrowth in humans”, Nature, vol. 403, pp. 383-384, (2000).
Samaridis, et al., “Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways”, Eur. J. Immunol., 27: 660-665, (1997).
Syken, et al., “PirB restricts ocular-dominance plasticity in visual cortex”, Science, vol. 313, pp. 1795-1800, (2006).
Takai, et al., “Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family”, Immunological Reviews, vol. 181, pp. 215-222, (2001).
Takai, et al., Paired immunoglobulin-like receptors and their MHC class recognition, Immunology, 115, pp. 433-440, (2005).
Wang, et al., “Oligodendrocyte-myelin glycoprotein is a nogo receptor ligand that inhibits neurite outgrowth”, Nature, vol. 417, pp. 941-944, (2002).
Wang, et al., “p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp”, Nature, vol. 420, pp. 74-78, (2002).
Wong, et al., “A p75NTRand Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein”, Nature Neuroscience, vol. 5, No. 12, pp. 1302-1308, (2002).
Zheng, et al., “Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo”, PNAS, vol. 102, No. 4, pp. 1205-1210, (2005).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modulators of neuronal regeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of neuronal regeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of neuronal regeneration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2648959

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.